Ligand Pharmaceuticals | LGND - 流动负债



金融业
股票价格
USD
资产
USD 2.19B
现金及等价物
USD 1.01B
销售成本
USD 11.31M
流动资产
USD 1.46B
流动负债
USD 46.74M
债务
USD 451.98M
EBIT
USD 56.62M
EBITDA
USD -14.3M
员工
68
EPS每股收益
USD 2.37
股本和储备
USD 967.52M
销售毛利
USD 100.41M
债务利息支出
USD 1.79M
利息收入
USD 6.66M
贷款资金
USD 446.9M
市值
USD 5.11B
净收入
USD 48.51M
营业费用
USD 55.1M
营业利润
USD 56.62M
普通股股本
USD 19.66M
PE价格收益
84.31
税前利润
USD -24.26M
销售收入
USD 83.7M
销售和管理费用
USD 29.12M
股票
USD 10.26M
贸易债权人
USD 9.41M
应收帐款人
USD 54.8M


流动负债 更改 日
Agenus USD 231.82M 17.42M 2026-06
Amgen USD 25.5B 547M 2026-06
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
Baxter International USD 3.59B 102M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Enviri Corporation USD 640.69M 6.67M 2026-03
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Glaxosmithkline GBP 22.43B 6.39B 2026-03
Heron Therapeutics USD 92.14M 1.63M 2026-06
Insmed USD 438.74M 77.74M 2026-06
Intrexon USD 23.02M 38K 2024-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Ligand Pharmaceuticals USD 46.74M 6.07M 2026-06
MacroGenics USD 108.82M 12.88M 2026-06
Merck USD 27.73B 786M 2026-06
Pacira USD 122.01M 13.22M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Veracyte USD 62.74M 6.62M 2026-06